Cytotoxicity and Antibacterial Effect of Trp-Substituted CM11 Cationic Peptide Against Drug-Resistant Isolates of Brucella melitensis Alone and in Combination with Recommended Antibiotics
- 89 Downloads
During the recent years, antibiotic resistance of pathogenic bacteria to conventional and common antibiotics has considered as a global concern. Therefore, researchers attend to find a new class of antimicrobial agents such as antimicrobial peptides (AMP), but some limitations are on the therapeutic use of AMPs such as cytotoxicity. To overcome these limitations various strategies have been described such as designing AMP analogues and/or combined use of them with synergistic effects. According to the many studies substitution of tryptophan as an amino acid residue with negative hydropathy index (− 0.9) to the leucine residue that is an amino acid with high positive hydropathy index (3.8) can enhance bactericidal activity and reduce cytotoxicity. Based on this topic in this study, a peptide modification was done by substitution of tryptophan at position 3 (leucine amino acid) of the CM11 antimicrobial peptide to promote its antibacterial activity and decrease cytotoxicity effect on eukaryotic cells. In the following, we investigated peptide antibacterial activity alone and in combination with common antibiotics against drug-resistant isolates of Brucella melitensis. Specific antibiotics were selected considering the CLSI guideline and peptide-antibiotics synergistic effect was done by checkerboard procedure through the broth microdilution method. In comparison with the CM11 peptide, modified peptide exhibited similar antimicrobial activity against clinical isolates of antibiotic-resistant B. melitensis with a reduction in hemolytic and cytotoxicity activates. Also, the synergistic effect between modified peptide and streptomycin and rifampin was observed as synergy and additive, respectively.
KeywordsBrucella melitensis Antibiotic resistance Antimicrobial peptide Synergistic effect Amino acid substitution
This study is extracted from a MSc thesis which was approved and supported by Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. The authors would like to thank colleagues in this centre for their kind and generous assistance.
Compliance with Ethical Standards
Conflict of interest
The authors declare that there are no conflicts of interest.
- Biemer JJ (1973) Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method Ann Clin Lab Sci 3:135–140Google Scholar
- Hasani SM, Mirnejad R, Amani J, javad Vafadar M (2016) Comparing rapid and specific detection of Brucella in clinical samples by PCR-ELISA and multiplex-PCR method. Iran J Pathol 11:144Google Scholar
- Heiat M, Aghamollaei H, Moghaddam MM, Kooshki H (2014) Using CM11 peptide as a cell permeable agent for the improvement of conventional plasmid transformation methods in Escherichia coli and Bacillus subtilis. Minerva Biotechnol 26:149–157Google Scholar
- Lorian V (2005) Antibiotics in laboratory medicine. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
- Moghaddam MM, Abolhassani F, Babavalian H, Mirnejad R, Barjini KA, Amani J (2012) Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli. Probiotics Antimicrob Proteins 4:133–139CrossRefGoogle Scholar
- Moghaddam MM, Barjini KA, Ramandi MF, Amani J (2014) Investigation of the antibacterial activity of a short cationic peptide against multidrug-resistant Klebsiella pneumoniae and Salmonella typhimurium strains and its cytotoxicity on eukaryotic cells. World J Microbiol Biotechnol 30:1533–1540. https://doi.org/10.1007/s11274-013-1575-y CrossRefGoogle Scholar
- Mohammadi Azad Z, Moravej H, Fasihi-Ramandi M, Masjedian F, Nazari R, Mirnejad R, Moosazadeh Moghaddam M (2017) In vitro synergistic effects of a short cationic peptide and clinically used antibiotics against drug-resistant isolates of Brucella melitensis. J Med Microbiol. https://doi.org/10.1099/jmm.0.000524 Google Scholar
- Piranfar V, Sharif M, Hashemi M, Vahdati AR, Mirnejad R (2015) Detection and discrimination of two Brucella species by multiplex real-time PCR and high-resolution melt analysis curve from human blood and comparison of results using RFLP. Iran J Basic Med Sci 18:909Google Scholar
- Rashidi K, Motaharinia Y, Rezaee MA, Asadzade N, Hazhir MS, Mohsenpour B, Hossaini W, Zandi F, Rahmani MR (2011) Determination of antibiotic resistance of Brucella spp. isolated from brucellosis patients in Kurdistan. J Large Anim Clin Sci Res 4:41–48 (in Persian) Google Scholar
- Saberi F, Kamali M, Taheri RA, Ramandi MF, Bagdeli S, Mirnejad R (2016) Development of surface plasmon resonance-based immunosensor for detection of Brucella melitensis. J Braz Chem Soc 27:1960–1965Google Scholar
- Wayne P (2011) Clinical and Laboratory Standards Institute; 2011 CLSI Performance standards for antimicrobial susceptibility testing 20th Informational Supplement CLSI document M100-S21Google Scholar